Search
Patexia Research
Case number 2024-1965

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. > Documents

Date Field Doc. No.Description (Pages)
Aug 29, 2024 38 ORDER filed; Samsung's motion [27] is granted only to the extent that Appeal Nos. 2024-1965 et al. and 2024-2009 et al. are designated companion cases and, separately, Appeal Nos. 2024-2002 and 2024-2058 are designated companion cases. The Clerk of Court shall transmit a copy of this order to the merits panels for these appeals. (Per Curiam). Service as of this date by the Clerk of Court. [1028863] [24-1965, 24-2002, 24-2009, 24-2058] [NL] [Entered: 08/29/2024 02:56 PM] (5)
Aug 26, 2024 37 MODIFIED ENTRY: CONFIDENTIAL RESPONSE BRIEF FILED by Appellee Regeneron Pharmaceuticals, Inc.. Service: 08/26/2024 by email. [1027789]--[Edited 08/29/2024 by JSP - compliance review complete] [David Berl] [Entered: 08/26/2024 11:01 PM] (0)
Aug 26, 2024 36 MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Regeneron Pharmaceuticals, Inc.. Service: 08/26/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1027788] --[Edited 08/29/2024 by JSP - compliance review complete] [David Berl] [Entered: 08/26/2024 10:58 PM] (85)
Aug 20, 2024 35 Confidential Defendant-Appellant Samsung Bioepis Co., Ltd.'s Reply in Support of its Motion to Stay Preliminary Injunction or Reconsider Order on Motion to Expedite filed by Appellant Samsung Bioepis Co., Ltd. corresponding to Doc. No. [34]. Service: 08/20/2024 by email. [1026492] [24-1965] [Raymond Nimrod] [Entered: 08/20/2024 09:37 PM] (0)
Aug 20, 2024 34 REPLY of Appellant Samsung Bioepis Co., Ltd. to response [32]. Service: 08/20/2024 by email. [1026490] [24-1965] [Raymond Nimrod] [Entered: 08/20/2024 09:29 PM] (22)
Aug 15, 2024 33 Confidential Opposition to Appellant's Motion to Stay Preliminary Injunction or Reconsider Order on Motion to Expedite corresponding to Doc. No. [32]. Service: 08/15/2024 by email. [1025486] [24-1965] [Jacob Hartman] [Entered: 08/15/2024 11:55 PM] (0)
Aug 15, 2024 32 RESPONSE of Appellee Regeneron Pharmaceuticals, Inc. to Doc No. [27]. Service: 08/15/2024 by email. [1025484] [24-1965] [Jacob Hartman] [Entered: 08/15/2024 11:50 PM] (42)
Aug 9, 2024 31 ORDER Regeneron Pharmaceuticals, Inc. is directed to respond to the motion [27] no later than 08/15/2024. Any reply in support of the motion is due no later than 08/20/2024. Service as of this date by the Clerk of Court. [1023917] [NL] [Entered: 08/09/2024 10:17 AM] (2)
Aug 8, 2024 30 Confidential Corrected Motion to stay pending appeal under Rule 8/18, or in the alternative, reconsider order filed by Appellant Samsung Bioepis Co., Ltd. corresponding to Doc. No. [27]. Service: 08/08/2024 by email. [1023836] [24-1965] [Raymond Nimrod] [Entered: 08/08/2024 04:53 PM] (0)
Aug 8, 2024 29 NOTICE OF NON-COMPLIANCE: The submission of Appellant Samsung Bioepis Co., Ltd., Confidential motion [28], is not in compliance with the rules of this court (see attached). Compliant document due on 08/15/2024. Service as of this date by the Clerk of Court. [1023628] [JSP] [Entered: 08/08/2024 11:13 AM] (2)
Aug 7, 2024 28 Confidential Motion to stay pending appeal under Rule 8/18, or in the alternative, reconsider order filed by Appellant Samsung Bioepis Co., Ltd. corresponding to Doc. No. [27]. Service: 08/07/2024 by email. [1023559] [24-1965] This document is non-compliant. See Doc No.[29] [Raymond Nimrod] [Entered: 08/07/2024 11:08 PM] (0)
Aug 7, 2024 27 MOTION of Appellant Samsung Bioepis Co., Ltd. Stay pending appeal under Rule 8/18, or in the alternative, reconsider order. Service: 08/07/2024 by email. [1023556] [24-1965] [Raymond Nimrod] [Entered: 08/07/2024 10:58 PM] (566)
Jul 30, 2024 26 Entry of Appearance for Laura Fairneny as counsel for Appellant Samsung Bioepis Co., Ltd.. Service: 07/30/2024 by email. [1021372] [24-1965] [Raymond Nimrod] [Entered: 07/30/2024 11:14 AM] (1)
Jul 29, 2024 25 ORDER granting motion to consolidate appeals [23] filed by Appellant Samsung Bioepis Co., Ltd.; Appeal Nos. 2024-1965 and 2024-1966 are consolidated with Appeal Nos. 2024-2082 and 2024-2083, and thus one set of briefs should be filed for the appeals. The revised official caption is reflected in this order. The respective due dates for briefing are unchanged. The Clerk of Court shall transmit a copy of this order to the merits panel. Service as of this date by the Clerk of Court. [1021106] [24-1965, 24-2082, 24-2083] [LMS] [Entered: 07/29/2024 02:33 PM] (2)
Jul 24, 2024 24 ORDER The motions to expedite ([1012654-2] [7]) are granted only to the extent that the court will place the appeals together on the next available oral argument calendar once briefing is completed. No extensions of time for the briefs should be anticipated. Consolidated Appeal Nos. 2024-1965 and 2024-1966; Appeal No. 2024-2002; consolidated Appeal Nos. 2024-2009 and 2024-2019; and Appeal No. 2024-2058 shall be considered companion cases and assigned to the same merits panel. The Clerk of Court shall transmit a copy of this order to the merits panel. Service as of this date by the Clerk of Court. [1020164] [24-1965, 24-1966] [NL] [Entered: 07/24/2024 09:40 AM] (5)
Jul 22, 2024 23 MOTION of Appellant Samsung Bioepis Co., Ltd. to consolidate appeals (24-1965, 24-1966, 24-2082, 24-2083). Service: 07/22/2024 by email. [1019732] [24-1965] [Raymond Nimrod] [Entered: 07/22/2024 06:44 PM] (9)
Jul 17, 2024 20 Amended Certificate of Interest for Appellant Samsung Bioepis Co., Ltd.. Service: 07/17/2024 by email. [1018390] [24-1965] [Raymond Nimrod] [Entered: 07/17/2024 09:39 AM] (3)
Jul 17, 2024 19 Notice of Related Case Information for Appellant Samsung Bioepis Co., Ltd.. Service: 07/17/2024 by email. [1018385] [24-1965] [Raymond Nimrod] [Entered: 07/17/2024 09:34 AM] (7)
Jul 17, 2024 21 MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Samsung Bioepis Co., Ltd.. Service: 07/17/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1018692] --[Edited 07/18/2024 by JSP - compliance review complete] [Raymond Nimrod] [Entered: 07/17/2024 11:07 PM] (279)
Jul 17, 2024 22 MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED by Appellant Samsung Bioepis Co., Ltd.. Service: 07/17/2024 by email. [1018693]--[Edited 07/18/2024 by JSP - compliance review complete] [Raymond Nimrod] [Entered: 07/17/2024 11:11 PM] (0)
Jul 10, 2024 18 Note to File: The following cases are consolidated: 24-1965 with 24-1966 Member case. The parties must file all documents in the lead appeal only. [1016614] [24-1965, 24-1966] [JSP] [Entered: 07/10/2024 11:06 AM] (0)
Jul 10, 2024 17 ORDER The appeals (24-1965 and 24-1966) are consolidated, and thus one set of briefs should be filed for both appeals. The revised official caption is reflected in this Order. Service as of this date by the Clerk of Court. [1016601] [24-1965, 24-1966] [NL] [Entered: 07/10/2024 10:46 AM] (2)
Jul 9, 2024 16 Corrected Entry of Appearance for David I. Berl; Thomas S. Fletcher; Andrew V. Trask; Shaun P. Mahaffy; Kathryn S. Kayali; Arthur J. Argall III; Adam Pan; Christian Gladden-Sorensen; Rhochelle Krawetz; Elizabeth S. Weiswasser; Priyata Patel; Jacob E. Hartman as counsel for Appellee Regeneron Pharmaceuticals, Inc.. Service: 07/09/2024 by email. [1016534] [24-1965] [David Berl] [Entered: 07/09/2024 08:29 PM] (3)
Jul 1, 2024 15 REPLY of Appellant Samsung Bioepis Co., Ltd. to response [13]. Service: 07/01/2024 by email. [1014802] [24-1965] [Raymond Nimrod] [Entered: 07/01/2024 09:44 PM] (10)
Jul 1, 2024 14 NOTICE OF NON-COMPLIANCE: The submission of Appellee Regeneron Pharmaceuticals, Inc., Entry of Appearance [9], is not in compliance with the rules of this court (see attached). Compliant document due on 07/09/2024. Service as of this date by the Clerk of Court. [1014451] [IMH] [Entered: 07/01/2024 10:04 AM] (2)
Jun 28, 2024 13 RESPONSE of Appellee Regeneron Pharmaceuticals, Inc. to Doc No. [7]. Service: 06/28/2024 by email. [1014389] [24-1965] [David Berl] [Entered: 06/28/2024 06:51 PM] (33)
Jun 28, 2024 12 Notice of Related Case Information for Appellee Regeneron Pharmaceuticals, Inc.. Service: 06/28/2024 by email. [1014378] [24-1965] [David Berl] [Entered: 06/28/2024 06:05 PM] (4)
Jun 28, 2024 11 Certificate of Interest for Appellee Regeneron Pharmaceuticals, Inc.. Service: 06/28/2024 by email. [1014377] [24-1965] [David Berl] [Entered: 06/28/2024 06:04 PM] (4)
Jun 28, 2024 10 Docketing Statement for the Appellee Regeneron Pharmaceuticals, Inc.. Service: 06/28/2024 by email. [1014376] [24-1965] [David Berl] [Entered: 06/28/2024 06:03 PM] (2)
Jun 28, 2024 9 Entry of Appearance for David I. Berl; Thomas S. Fletcher; Andrew V. Trask; Shaun P. Mahaffy; Kathryn S. Kayali; Arthur J. Argall III; Adam Pan; Christian Gladden-Sorensen; Rhochelle Krawetz; Elizabeth S. Weiswasser; Priyata Patel; Jacob E. Hartman as counsel for Appellee Regeneron Pharmaceuticals, Inc.. Service: 06/28/2024 by email. [1014370] [24-1965] This document is non-compliant. See Doc No.[14] [David Berl] [Entered: 06/28/2024 05:39 PM] (3)
Jun 24, 2024 8 ORDER Any opposition to the motion [7] is due no later than June 28, 2024. Any reply in support of the motion is due no later than three days thereafter. Service as of this date by the Clerk of Court. [1012810] [NL] [Entered: 06/24/2024 11:58 AM] (2)
Jun 21, 2024 7 MOTION of Appellant Samsung Bioepis Co., Ltd. to expedite briefing schedule. Service: 06/21/2024 by email. [1012650] [24-1965] [Raymond Nimrod] [Entered: 06/21/2024 04:43 PM] (19)
Jun 21, 2024 6 Certificate of Compliance with Fed. R. App. P. 10(b) [The Transcript of Proceedings] for Appellant Samsung Bioepis Co., Ltd.. Service: 06/21/2024 by email. [1012612] [24-1965] [Raymond Nimrod] [Entered: 06/21/2024 04:07 PM] (4)
Jun 21, 2024 5 Entry of Appearance for Raymond N. Nimrod; William B. Adams as counsel for Appellant Samsung Bioepis Co., Ltd.. Service: 06/21/2024 by email. [1012603] [24-1965] [Raymond Nimrod] [Entered: 06/21/2024 03:51 PM] (2)
Jun 21, 2024 4 Notice of Related Case Information for Appellant Samsung Bioepis Co., Ltd.. Service: 06/21/2024 by email. [1012598] [24-1965] [Raymond Nimrod] [Entered: 06/21/2024 03:44 PM] (7)
Jun 21, 2024 3 Docketing Statement for the Appellant Samsung Bioepis Co., Ltd.. Service: 06/21/2024 by email. [1012589] [24-1965] [Raymond Nimrod] [Entered: 06/21/2024 03:34 PM] (2)
Jun 21, 2024 2 Certificate of Interest for Appellant Samsung Bioepis Co., Ltd.. Service: 06/21/2024 by email. [1012586] [24-1965] [Raymond Nimrod] [Entered: 06/21/2024 03:27 PM] (3)
Jun 20, 2024 1 Appeal docketed. Received: 06/17/2024. [1012085]Entry of Appearance is due on 07/05/2024. Certificate of Interest is due on 07/05/2024. Docketing Statement is due on 07/05/2024. Appellant's brief is due on 08/19/2024. [JSP] [Entered: 06/20/2024 11:48 AM] (62)
Menu